Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LifeMD (LFMD)
NASDAQ:LFMD
LFMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.99 - $12.88
Previous CloseN/A
Volume302.38K
Average Volume (3M)767.61K
Market Cap
$325.71M
Enterprise Value$209.51M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.23
Next Earnings
Apr 08, 2025EPS Estimate
-0.05Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.64
Shares Outstanding43,312,120
10 Day Avg. Volume1,166,687
30 Day Avg. Volume767,614
Standard Deviation0.49
R-Squared0.03
Alpha0.09
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.79
Price to Cash Flow (P/CF)13.90
P/FCF Ratio25.90
Enterprise Value/Market Cap0.64
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit1.57
Enterprise Value/Ebitda-20.05
Forecast
1Y Price Target
$9.50Price Target Upside26.33% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
---
LifeMD News
PremiumCompany Announcements
LifeMD Sets New CEO Compensation Strategy
---
Bulls Say, Bears Say
Bulls Say
Growth ProspectsLifeMD has accelerated growth due to the successful uptake of its virtual 'GLP-1 Weight Management' program within its core Telehealth segment.
Revenue GuidanceManagement reiterated 2024 revenue guidance of at least $205M, with adjusted EBITDA now in the range of $13-14M.
Bears Say
Regulatory RiskThe FDA announced its intention to take tirzepatide off the FDA drug shortage list, meaning compounding would no longer be allowed, causing LFMD's stock to slide.
---
Ownership Overview
13.55% Insiders
8.92% Mutual Funds
8.87% Other Institutional Investors
60.97% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Ability to SellRisks related to the company’s ability to sell goods and services
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
LFMD FAQ
What was LifeMD’s price range in the past 12 months?
LifeMD lowest stock price was $3.99 and its highest was $12.88 in the past 12 months.
What is LifeMD’s market cap?
LifeMD’s market cap is $325.71M.
When is LifeMD’s upcoming earnings report date?
LifeMD’s upcoming earnings report date is Apr 08, 2025 which is in 45 days.
How were LifeMD’s earnings last quarter?
LifeMD released its earnings results on Nov 07, 2024. The company reported -$0.14 earnings per share for the quarter, missing the consensus estimate of -$0.118 by -$0.022.
Is LifeMD overvalued?
According to Wall Street analysts LifeMD’s price is currently Undervalued.
Does LifeMD pay dividends?
LifeMD does not currently pay dividends.
What is LifeMD’s EPS estimate?
LifeMD’s EPS estimate is -0.05.
How many shares outstanding does LifeMD have?
LifeMD has 43,312,120 shares outstanding.
What happened to LifeMD’s price movement after its last earnings report?
LifeMD reported an EPS of -$0.14 in its last earnings report, missing expectations of -$0.118. Following the earnings report the stock price went up 14.035%.
Which hedge fund is a major shareholder of LifeMD?
Currently, no hedge funds are holding shares in LFMD
---
LifeMD Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$9.50 (26.33% Upside)
$9.50 (26.33% Upside)
Blogger Sentiment
Bullish
LFMD Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 42.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $292.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 4.3%
Last 30 Days ▲ 0.4%
Last 30 Days ▲ 0.4%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
4.58%
12-Months-Change
Fundamentals
Return on Equity
301.60%
Trailing 12-Months
Asset Growth
78.32%
Trailing 12-Months
Company Description
LifeMD
Conversion Labs, Inc. engages in the manufacturing, distribution, and sale of natural immune support products containing proprietary yeast beta glucans. Its products are oral intake tablets and topical creams, and gels for skin application. It operates through the Finished Cosmetic Products and Nutraceutical and Cosmetic Additives segments. The company was founded in 1987 and is headquartered in New York, NY.
---
LFMD Company Deck
---
LFMD Earnings Call
Q3 2024
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflected a strong performance in LifeMD's telehealth business, with significant revenue growth, improved profitability, and strategic expansions in pharmacy operations. However, challenges remain with GLP-1 therapy coverage and maintaining growth in WorkSimpli's subscriber base. Despite these issues, the overall sentiment leans positive due to robust growth and financial results.Read More>---
LFMD Stock 12 Month Forecast
Average Price Target
$9.50
▲(26.33% Upside)
Technical Analysis
Best Analysts Covering LFMD
1 Year
1 Year Success Rate
10/30 ratings generated profit
1 Year Average Return
+19.05%
reiterated a buy rating 4 months ago
Copying David Larsen's trades and holding each position for 1 Year would result in 33.33% of your transactions generating a profit, with an average return of +19.05% per trade.
---